K. Yasuhara et al., Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action, CARCINOGENE, 22(4), 2001, pp. 613-618
To cast light on whether xylazine hydrochloride (XZ), a veterinary medicine
commonly used as a sedative agent for food-producing animals, has any prom
oting potential for thyroid carcinogenesis, the following studies were perf
ormed, In Experiment I, male F344 rats received a diet containing 1000 or 0
p.p.m, XZ for 52 weeks with or without initiation with 2400 mg/kg N-bis(2-
hydroxypropyl)nitrosamine (DHPN), Focal follicular cell hyperplasias, adeno
mas and/or carcinomas were induced in the DHPN alone, XZ alone and DHPN + X
Z groups, and the incidences and multiplicities of these lesions in the DHP
N + XZ group were significantly increased as compared with the DHPN alone c
ase. In Experiment II, male F344 rats received a diet containing 1000 or 0
p,p,m, XZ and were examined for serum levels of triiodothyronine (T-3), thy
roxine (T-4) and thyroid-stimulating hormone (TSH) at weeks 1, 2 and 4, In
the XZ group, significant increase in thyroid weight and decrease in serum
T-4 levels were observed at all time points. Serum T-3 and TSH levels were
significantly decreased and increased, respectively, at week 1, but returne
d to within the control range thereafter, In Experiment III, male F344 rats
received a diet containing 1000 or 0 p,p,m, XZ, they were examined for thy
roid iodine uptake and organification of XZ after 1 and 2 weeks. The thyroi
dal iodine uptake per milligram of thyroid and the amount of iodine bound t
o 1 mg protein showed a tendency for decrease at week 1 and significant dec
rease at week 2, These results indicate that XZ has tumor-promoting effects
on thyroid follicular cells, and suggest an involvement of alterations in
thyroid-related hormone levels due to inhibition of thyroid iodine uptake a
nd organification, resulting, provably, in serum TSH stimulation depending
on continuous reduction of serum T-4 level through the feedback system in t
he pituitary-thyroid axis.